Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China.
Eur J Med Chem. 2009 Nov;44(11):4674-80. doi: 10.1016/j.ejmech.2009.07.011. Epub 2009 Jul 16.
A series of novel naphthalimide derivatives with flexible alkyl/aryl moieties were designed and synthesized. Their antitumor activities were evaluated against HeLa, A549, P388, HL-60, MCF-7, HCT-8 and A375 cancer cell lines in vitro. The preliminary results showed that most of the derivatives had comparable antitumor activities over Amonafide with the IC(50) values of 10(-6) to 10(-5)M. More importantly, flow cytometric analysis indicated that the derivatives could effectively induce G(2)/M arrest and progress to apoptosis in HL-60 cell line after double staining with annexin V-FITC and propidium iodide. The present work provided a novel class of naphthalimide-based derivatives with potent apoptosis-inducing and antitumor activities for further optimization.
一系列具有柔性烷基/芳基部分的新型萘酰亚胺衍生物被设计和合成。它们的抗肿瘤活性被评估,包括对 HeLa、A549、P388、HL-60、MCF-7、HCT-8 和 A375 癌细胞系的体外活性。初步结果表明,大多数衍生物的抗肿瘤活性与 Amonafide 相当,IC(50)值为 10(-6)到 10(-5)M。更重要的是,流式细胞术分析表明,这些衍生物在用 Annexin V-FITC 和碘化丙啶双重染色后,可以有效地诱导 HL-60 细胞系中的 G(2)/M 期阻滞并向凋亡进展。本工作提供了一类具有潜在凋亡诱导和抗肿瘤活性的新型萘酰亚胺类衍生物,可进一步优化。